Infectious Diseases | sciencenewsnet.in

UCI researchers launch first-of-its-kind coronavirus statistics portal

August 10, 2020 sarah Jonas Centers, Computer Science, Coronavirus, COVID-19, Faculty, Graduate Students, Infectious Diseases, Public Health, Statistics, Technology

Irvine, Calif., Aug. 10, 2020 — Scientists at the University of California, Irvine have unveiled a public website that provides up-to-date statistics on coronavirus infections in Orange County, with comparisons to neighboring and other California counties. The site displays information collected from the California Open Data Portal in an easily comprehended format, giving visitors quick access to the most relevant data on hospitalized patients with COVID-19, intensive care unit patients, new daily cases and new daily deaths caused by the disease.

Announcement

Texas Biomed adds International Global Health Expert to Leadership Team

August 5, 2020 sarah Jonas Donor, Fundraising, Infectious Diseases, Philanthropy

The leadership team at Texas Biomedical Research Institute is excited to announce the addition of Akudo Anyanwu, M.D., M.P.H. to its administrative leadership team as Vice President of Development.

Expert Pitch

Rutgers Expert Can Discuss Global Climate Change Mortality Study

August 3, 2020 sarah Jonas Adaptation, AIDS, Air Conditioning, Cancer, Carbon Dioxide, carbon dioxide emissions, Carbon Emissions, Climate, Climate Change, Climate Impact Lab, Death Rate, Dengue, Economics, Emissions, Environment, extreme heat, Health, Heart Disease, heat, high emissions scenario, HIV, Infectious Diseases, Malaria, Mortality, New Jersey, NJ, poor, Research, Rhodium Group, Rutgers, Rutgers Institute of Earth, Ocean, and Atmospheric Sciences, Rutgers University, Rutgers University-New Brunswick, Science, Tuberculosis, University of California, Berkeley, Yellow Fever

Research Results

Different approach needed to ‘buy time’ and tackle COVID-19

July 15, 2020 sarah Jonas ACE2 expression, COVID-19, Infectious Diseases, Pharmaceucticals, Virus

A prominent Australian pharmacologist has called for a new approach to treating COVID-19 as hopes fade of finding an effective vaccine or antiviral before the end of the year.

Research Results

Does Blood Plasma from COVID-19 Survivors Help Patients Infected with Novel Coronavirus?

July 9, 2020 sarah Jonas Blood Donation, blood plasma, Clinical Trials, COVID-19, Infectious Diseases, novel coronavirus, Public Health, SARS-CoV-2

Researchers at University of California San Diego School of Medicine and UC San Diego Health have launched a clinical trial to assess the safety and efficacy of convalescent plasma (CP) to prevent COVID-19 after a known exposure to the virus.

Feature

FAU Now Offers COVID-19 Contact Tracing and Risk-Reduction Public Health Certificate

June 15, 2020 sarah Jonas Certificates, contact tracing, Coronavirus, COVID-19, Employment, EPIDEMIOLOGY, Infection Control, Infectious Diseases, Nursing, Pandemic, Public Health, Quarantine, social distancing, Testing, Virus

In response to the high demand for one of the fastest-growing jobs in the U.S., FAU has launched a new, online public health certificate course on COVID-19, contact tracing and risk-reduction. The five-week, 15-hour course does not require a college degree and is scheduled from June 29 to Aug. 7. The program is open to the general public for adults age 18 and older with a high school diploma or equivalent and a variety of work experiences and educational backgrounds.

Research Results

COVID-19: Antibody testing to reveal extent of infections across Va.

June 5, 2020 sarah Jonas antibody testing, Coronavirus, COVID-19, Infectious Diseases, University Of Virginia, University of Virginia School of Medicine, UVA School of Medicine, Virginia

UVA Health has partnered with the Virginia Department of Health and other hospitals around the state to determine how many Virginians have been infected with COVID-19 – and how many remain at risk.

Feature Expert

Research and innovation as an essential function amid the COVID-19 pandemic

April 29, 2020 sarah Jonas Clinical & Translational Research, Clinical Trial, convalescent plasma therapy, Coronavirus, COVID-19, Engineering, Hospitals, Infection Control, Infectious Diseases, Inhalers, Innovation, Medicine, N95 masks, novel coronavirus, personal protective equipment, PPE, remdesivir, Research, Ventilators

Necessity being the mother of invention, Houston Methodist clinicians, researchers and staff have collaborated on a number of clinical device and research innovations in response to COVID-19. Houston Methodist Academic Institute leadership has continually emphasized translational research in new technologies.

Research Results

Loss of Smell Associated with Milder Clinical Course in COVID-19

April 27, 2020 sarah Jonas Allergy, Anosmia, COVID-19, ear, nose and throat, Infectious Diseases, novel coronavirus, Otolaryngology, Rhinology, SARS-CoV-2

Researchers at UC San Diego Health report in newly published findings that olfactory impairment suggests the resulting COVID-19 disease is more likely to be mild to moderate, a potential early indicator that could help health care providers determine which patients may require hospitalization.

Research Results

Artificial Intelligence Enables Rapid COVID-19 Lung Imaging Analysis at UC San Diego Health

April 7, 2020 sarah Jonas Bioinformatics, Coronavirus, COVID – 19, Diagnostics, Imaging, Infectious Diseases, Pneumonia, Pulmonology, Radiology, SARS-CoV-2, SARS-CoV-2 testing, VIROLOGY, X-Ray

With support from Amazon Web Services, UC San Diego Health physicians are using AI in a clinical research study aimed at speeding the detection of pneumonia, a condition associated with severe COVID-19.

Feature

Tested and Testing: UC San Diego Health Expands COVID-19 Diagnostics

April 6, 2020 sarah Jonas Coronavirus, COVID-19, Diagnostics, EPIDEMIOLOGY, Infectious Diseases, Laboratory Medicine, Pathology, Rapid Testing

UC San Diego Health makes measurable progress addressing COVID-19 testing shortage through multiple partnerships and rapidly growing in-house testing. Success has meant more testing for more patients, first responders and other health systems.

Research Results

UC San Diego Health Launches Clinical Trial to Assess Antiviral Drug for COVID-19

March 24, 2020 sarah Jonas Clinical Trial, Coronavirus, COVID-19, Infectious Diseases, remdesivir, SARS-CoV-2

Researchers at four University of California Health medical centers have begun recruiting participants for a Phase II clinical trial to investigate the safety and efficacy of treating adult patients with COVID-19 with remdesivir, a drug that has shown promising activity against multiple viruses.

← Previous